CATCo Regulatory News (CAT)

13 Jul 2006 16:12

Cambridge Antibody Tech Group PLC13 July 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Cambridge Antibody Technology Group plc 2. Name of shareholder having a major interest Wellington Management Company 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 Non beneficial 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them Not known 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed Not known 8. Percentage of issued class Not known 9. Class of security Ordinary 10 pence shares 10. Date of transaction Not known 11. Date company informed 12 July 2006 12. Total holding following this notification Not known 13. Total percentage holding of issued class following this notification Not known 14. Any additional information The Company has been notified that Wellington Management Company no longer havea notifiable interest in the ordinary shares of the Company 15. Name of contact and telephone number for queries Justin Hoskins, 01223 898589 16. Name and signature of authorised company official responsible for makingthis notification Adrian Kemp, Director Date of notification 13 July 2006 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Cambridge Antibody Technology Group plc 2. Name of shareholder having a major interest Credit Suisse Securities (Europe) Limited 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 Non beneficial 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them Not known 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed Not known 8. Percentage of issued class Not known 9. Class of security Ordinary 10 pence shares 10. Date of transaction Not known 11. Date company informed 12 July 2006 12. Total holding following this notification Not known 13. Total percentage holding of issued class following this notification Not known 14. Any additional information The Company has been notified that Credit Suisse Securities (Europe) Limited nolonger have a notifiable interest in the ordinary shares of the Company 15. Name of contact and telephone number for queries Justin Hoskins, 01223 898589 16. Name and signature of authorised company official responsible for makingthis notification Adrian Kemp, Director Date of notification 13 July 2006 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange